MED7 Antikörper
Kurzübersicht für MED7 Antikörper (ABIN2460796)
Target
Alle MED7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Antibody is purified by peptide affinity chromatography method.
-
Immunogen
- Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human CRSP9.
-
-
-
-
Applikationshinweise
- CRSP9 antibody can be used for detection of CRSP9 by ELISA at 1:312500. CRSP9 antibody can be used for detection of CRSP9 by western blot at 0.25 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 50 ?L of distilled water. Final antibody concentration is 1 mg/mL.
-
Konzentration
- 1 mg/mL
-
Buffer
- Antibody is lyophilized in PBS buffer with 2 % sucrose.
-
Handhabung
- As with any antibody avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- For short periods of storage (days) store at 4 °C. For longer periods of storage, store CRSP9 antibody at -20 °C.
-
-
- MED7 (Mediator Complex Subunit 7 (MED7))
-
Andere Bezeichnung
- CRSP9
-
Hintergrund
- CRSP9 is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. CRSP9 is also a component of other multisubunit complexes e.g. thyroid hormone receptor- (TR-) associated p
-
Molekulargewicht
- 27 kDa
-
Gen-ID
- 9443
-
NCBI Accession
- NP_004261
-
UniProt
- O43513
-
Pathways
- Stem Cell Maintenance, Regulation of Lipid Metabolism by PPARalpha
Target
-